These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23076480)

  • 21. Hypoglycemia in patients with type 2 diabetes using concomitant exenatide BID and long-acting insulin therapy.
    Pawaskar MD; Blickensderfer AL; Hoogwerf BJ; Quimbo R; Wade R
    J Med Econ; 2011; 14(6):705-8. PubMed ID: 21892855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin analogs versus human insulin in type 2 diabetes.
    Migdalis IN
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S102-4. PubMed ID: 21864739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Modern medical treatment of type 2 diabetes].
    Hanefeld M; Bornstein SR; Barthel A
    Dtsch Med Wochenschr; 2014 Dec; 139(49):2494-7. PubMed ID: 25423454
    [No Abstract]   [Full Text] [Related]  

  • 24. European Medicines Agency must take account of cardiovascular harm associated with degludec insulin.
    Schmidt TA; Rosen CJ; Yudkin JS
    BMJ; 2013 Jun; 346():f3731. PubMed ID: 23757746
    [No Abstract]   [Full Text] [Related]  

  • 25. Incidence rates of heart failure, stroke, and acute myocardial infarction among Type 2 diabetic patients using insulin glargine and other insulin.
    Juhaeri J; Gao S; Dai WS
    Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):497-503. PubMed ID: 19326365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical use of long-acting insulin analogs].
    Birkeland KI
    Tidsskr Nor Laegeforen; 2006 Apr; 126(8):1067-8. PubMed ID: 16619068
    [No Abstract]   [Full Text] [Related]  

  • 27. [Medicines for type 2 diabetes: fine tuning rather than redesign].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2012 May; 35(5):163. PubMed ID: 22624349
    [No Abstract]   [Full Text] [Related]  

  • 28. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
    Fischer JS; McLaughlin T; Loza L; Beauchamp R; Schwartz S; Kipnes M
    Curr Med Res Opin; 2004 Nov; 20(11):1703-10. PubMed ID: 15537471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination therapy with insulin glargine and exenatide: real-world outcomes in patients with type 2 diabetes.
    Levin P; Wei W; Wang L; Pan C; Douglas D; Baser O
    Curr Med Res Opin; 2012 Mar; 28(3):439-46. PubMed ID: 22216894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].
    MMW Fortschr Med; 2012 Feb; 154(3):82-3. PubMed ID: 22458177
    [No Abstract]   [Full Text] [Related]  

  • 31. Insulin degludec (Tresiba)--a new long-acting insulin for diabetes.
    Med Lett Drugs Ther; 2015 Dec; 57(1483):163-4. PubMed ID: 26633683
    [No Abstract]   [Full Text] [Related]  

  • 32. Metformin: diamonds are forever.
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in insulin therapy: a review of insulin degludec.
    King A
    J Fam Pract; 2012 May; 61(5 Suppl):S28-31. PubMed ID: 22577639
    [No Abstract]   [Full Text] [Related]  

  • 34. Type 2 diabetes - controlling hyperglycaemia with early insulin use.
    MacIsaac R; Cheung A; Jerums G
    Aust Fam Physician; 2010 Aug; 39(8):565-9. PubMed ID: 20877750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initiating and intensifying insulin therapy for type 2 diabetes: why, when, and how.
    Cobble ME
    Am J Ther; 2009; 16(1):56-64. PubMed ID: 19142156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin analogues in the treatment of gestational diabetes mellitus.
    Durnwald CP
    Clin Obstet Gynecol; 2013 Dec; 56(4):816-26. PubMed ID: 24022504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin therapy for diabetes mellitus: treatment regimens and associated costs.
    Charbonnel B; Penfornis A; Varroud-Vial M; Kusnik-Joinville O; Detournay B
    Diabetes Metab; 2012 Apr; 38(2):156-63. PubMed ID: 22172400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Capabilities of hypoglycemic therapy in women with decompensated type 2 diabetes mellitus].
    Onuchin SG; Elsukova OS; Solov'ev OV; Onuchina EL
    Ter Arkh; 2010; 82(8):34-41. PubMed ID: 20873243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type 2 diabetes treatment and macrovascular complications--fat and sugar make a dangerous soufflé.
    Bajaj M; Jialal I
    Metab Syndr Relat Disord; 2009 Apr; 7(2):79-81. PubMed ID: 19351292
    [No Abstract]   [Full Text] [Related]  

  • 40. [Insulin therapy in type 2 diabetes: short-acting insulin analog has advantages].
    MMW Fortschr Med; 2006 Jun; 148(26):56-7. PubMed ID: 16875384
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.